BMY

SEC source: 0000014272-24-000060 · wk-form4_1710280224.xml · derivative · entry 4

Shanahan Karin · CIK 0001917325 · EVP, Glob. Prod. Dev. & Supply

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,880

Underlying: Common Stock, $0.10 par value · 3,293 shares

Expires 2027-03-10

F2 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F5 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000060 · wk-form4_1710280224.xml · derivative · entry 3

Shanahan Karin · CIK 0001917325 · EVP, Glob. Prod. Dev. & Supply

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,895

Underlying: Common Stock, $0.10 par value · 2,447 shares

Expires 2026-03-10

F2 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F3 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 16

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,026

Underlying: Common Stock, $0.10 par value · 148,026 shares

Expires 2027-03-10

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 15

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 41,910 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F12 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 14

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,684

Underlying: Common Stock, $0.10 par value · 98,684 shares

Expires 2028-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 13

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,199

Underlying: Common Stock, $0.10 par value · 6,733 shares

Expires 2027-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 12

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,234

Underlying: Common Stock, $0.10 par value · 6,616 shares

Expires 2026-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F9 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 11

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,985

Underlying: Common Stock, $0.10 par value · 6,985 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · derivative · entry 10

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 5,743 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 9

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,205

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 8

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,180

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 7

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 6

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,859

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 5

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,816

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 4

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 3

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,035

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 2

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,510

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000062 · wk-form4_1710287881.xml · nonDerivative · entry 1

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 16

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,029

Underlying: Common Stock, $0.10 par value · 11,029 shares

Expires 2027-03-10

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 15

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 2,094 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F12 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 14

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,353

Underlying: Common Stock, $0.10 par value · 7,353 shares

Expires 2028-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 13

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,601

Underlying: Common Stock, $0.10 par value · 867 shares

Expires 2027-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 12

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,822

Underlying: Common Stock, $0.10 par value · 910 shares

Expires 2026-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F9 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 11

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349

Underlying: Common Stock, $0.10 par value · 349 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · derivative · entry 10

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 318 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 9

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,432

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 8

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,926

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 7

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 6

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 561

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 5

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 666

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 4

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 3

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 2

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000065 · wk-form4_1710288027.xml · nonDerivative · entry 1

Gallman Cari · CIK 0001995058 · EVP, Corporate Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 16

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,546

Underlying: Common Stock, $0.10 par value · 7,546 shares

Expires 2027-03-10

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 15

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 3,268 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F12 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 14

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,031

Underlying: Common Stock, $0.10 par value · 5,031 shares

Expires 2028-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 13

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,152

Underlying: Common Stock, $0.10 par value · 1,050 shares

Expires 2027-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 12

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,673

Underlying: Common Stock, $0.10 par value · 835 shares

Expires 2026-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F9 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 11

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 546

Underlying: Common Stock, $0.10 par value · 544 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · derivative · entry 10

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 539 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 9

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,726

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 8

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,643

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 7

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,781

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 6

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 5

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 707

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 4

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 801

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 3

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 2

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

SEC source: 0000014272-24-000067 · wk-form4_1710288103.xml · nonDerivative · entry 1

Hoch Lynelle · CIK 0002005382 · President, Cell Therapy Org.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 539

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.